IP Library Granted Patent US 7,419,832
Granted Patent B2
US 7,419,832 · App. 11/369,928 · Granted Sep 2, 2008

Blood collection tube with surfactant

Assignee: Streck, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,419,832
App. No.
11/369,928
Granted
Sep 2, 2008
Kind
B2
Abstract

Improvements in blood collection and testing. In one aspect, an improved method of manufacturing a blood collection tube, particularly illustrated for use in sedimentation rate testing, including providing an elongated glass tube with an open first end for receiving a venipuncture blood sample of at least 1 ml, formed with a closed end opposite the first end; and applying to a substantial portion of the receptacle a containment barrier. The improvements also pertain to resulting blood collection tubes, additives for blood collection tubes that permit reliable sedimentation test data after 8 hours from the blood draw, and methods of administering health care using the aforenoted tubes, additives or both.

Claims (15)

1. A method of managing the diagnosis and treatment of a condition, comprising the steps of:

a) coordinating the delivery of a blood sampling kit to at least one remote blood draw site, where blood samples are drawn from each of a plurality of persons directly into a tube corresponding to each person, wherein each tube has a containment barrier on the exterior of the tube and a surfactant inside of the tube;

b) performing an erythrocyte sedimentation rate (ESR) analysis on each of the plurality of blood samples located in the tubes at a remote site more than 6 hours after each sample is drawn;

c) receiving information at any site about the results of the ESR analysis of each blood sample; and

d) based on the results, coordinating administering a pharmacological therapy to a plurality of such persons whose blood sample indicates treatment is necessary.

2. The method of claim 1 , wherein the coordinating step (a) includes providing an elongated glass tube with an open first end for receiving a venipuncture blood sample of at least 1 ml, formed with a closed end opposite the first end.

3. The method of claim 2 , further comprising applying to a substantial portion of the glass tube a containment barrier that is sufficiently transparent that accurate and reproducible sedimentation rate tests are obtainable by an optical detection technique, and following a fracture of the tube, blood is contained within the tube.

4. The method of 3 , further comprising a step of evacuating the elongated glass tube to below atmospheric pressure and sealing the evacuated glass tube.

5. The method of claim 3 , further comprising a step of introducing into the tube, prior to introducing any blood, an additive including a surfactant and at least one additional additive selected from the group consisting of an anti-microbial, an anti-coagulant, a preservative, and any combination thereof.

6. The method of claim 5 , wherein the surfactant is a nonionic surfactant of the form C x E y , where C is an alkyl chain and E is a polyoxyethelyne chain, x is the number of carbons in the alkyl chain (C) and y is the number of ethyiene oxide units in the polyoxyethylene chain (E).

7. The method of claim 6 , wherein x is from about 6 to about 18 and y is from about 4 to about 40.

8. The method of claim 7 , wherein the surfactant is present in sufficient amount that it is capable of providing reproducible sedimentation rate tests, in a consistent and reproducible manner that approximates that of a fresh blood sample, after a delay of more than about 12 hours.

9. The method of claim 8 , further comprising refrigerating the blood sample before testing it.

10. The method of claim 9 , wherein the temperature of the sample is maintained between about 2 to about 10° C.

11. The method of claim 8 , further comprising maintaining the blood sample at ambient temperature before testing it.

Assignments (4)
SECURITY INTEREST Recorded Feb 21, 2023
From: STRECK LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 062819/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2023
From: STRECK, INC.
To: STRECK LLC
Reel/Frame 062766/0015 →
SECURITY INTEREST Recorded Apr 23, 2021
From: STRECK, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 056016/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2019
From: HUNSLEY, BRADFORD A.; RYAN, WAYNE L., PHD
To: STRECK, INC.
Reel/Frame 048058/0194 →
Continuity (2)
Provisional Application 6066028400 · Mar 10, 2005
Related Publication 20060210429A1 · Sep 21, 2006